Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2025-12-25 @ 7:19 PM
NCT ID: NCT02255032
Description: None
Frequency Threshold: 0
Time Frame: 8 weeks
Study: NCT02255032
Study Brief: Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
4 mg CLS-TA Single unilateral, suprachoroidal injection of 40 mg/mL (4 mg in 100 µL) of CLS-TA 4 mg CLS-TA: 4 mg/mL CLS-TA, Clearside's formulation of TA (CLS-TA, triamcinolone acetonide injectable suspension) 0 None 1 17 14 17 View
0.8 mg CLS-TA Single unilateral, suprachoroidal injection of 8 mg/mL (0.8 mg in 100 µL) of CLS-TA 0.8 mg CLS-TA: 0.8 mg/mL CLS-TA, Clearside's formulation of TA (CLS-TA, triamcinolone acetonide injectable suspension) 0 None 0 5 5 5 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Atrial fibrillation NON_SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (17.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Contusion NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.0) View
Palpitations NON_SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (17.0) View
Anterior chamber cell NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Anterior chamber inflammation NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Blindness transient NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Conjunctival haemorrhage NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Conjunctival haemorrhage NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Conjunctival oedema NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Dry eye NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Dry eye NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Eye pain NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Foreign body sensation in eyes NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Keratitis NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Macular oedema NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Macular oedema NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Ocular discomfort NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Punctate keratitis NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Retinal artery occlusion NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Uveitis NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Uveitis NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Visual acuity reduced NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.0) View
Injection site pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Papillitis NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Papillitis NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.0) View
Bronchitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.0) View
Gastrointestinal infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.0) View
Sinusitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.0) View
Tooth infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.0) View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.0) View
Fall NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (17.0) View
Blood pressure diastolic increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.0) View
Blood pressure systolic increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.0) View
Heart rate decreased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.0) View
Intraocular pressure increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.0) View
Intraocular pressure increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.0) View
Arthralgia NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.0) View
Substance-induced psychotic disorder NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.0) View
Hypertension NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (17.0) View